Discounted Cash Flow Rating
Sell
Return on Equity Rating
Strong Buy
Debt to Equity Rating
Strong Sell
Price to Earnings Rating
Strong Buy
Analyst Rating
Neutral
Simple Moving Average
Strong Buy
Exponential Moving Average
Buy
Relative Strength Index
Buy
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Neutral
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Buy
A
PTC Therapeutics, Inc. (PTCT)
Pharmaceutical Preparations
PTC Therapeutics Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when an RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.
100 CORPORATE COURT
SOUTH PLAINFIELD, NJ
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
06/20/2013
Market Cap
2,507,728,920
Shares Outstanding
75,460,000
Weighted SO
75,463,145
Total Employees
N/A
Upcoming Earnings
08/01/2024
Similar Tickers
Beta
0.6490
Last Div
0.0000
Range
17.53-41.93
Chg
-0.4400
Avg Vol
840474
Mkt Cap
2507728920
Exch
NASDAQ
Country
US
Phone
908 222 7000
DCF Diff
31.2168
DCF
-0.4317
Div Yield
0.0000
P/S
2.7850
EV Multiple
-44.2296
P/FV
-2.5518
Div Yield %
0.0000
P/E
-5.2162
PEG
-0.1612
Payout
0.0000
Current Ratio
2.2268
Quick Ratio
2.1746
Cash Ratio
1.0738
DSO
75.8615
DIO
57.9529
Op Cycle
133.8144
DPO
44.2104
CCC
89.6040
Gross Margin
0.7774
Op Margin
-0.2154
Pretax Margin
-0.5487
Net Margin
-0.5325
Eff Tax Rate
0.0295
ROA
-0.2502
ROE
0.5703
ROCE
-0.1484
NI/EBT
0.9705
EBT/EBIT
2.5474
EBIT/Rev
-0.2154
Debt Ratio
0.1570
D/E
-0.3069
LT Debt/Cap
-0.4096
Total Debt/Cap
-0.4428
Int Coverage
-14.4107
CF/Debt
-0.3840
Equity Multi
-1.9551
Rec Turnover
4.8114
Pay Turnover
8.2560
Inv Turnover
6.2982
FA Turnover
7.3135
Asset Turnover
0.4699
OCF/Share
-1.5054
FCF/Share
-2.9996
Cash/Share
14.2495
OCF/Sales
-0.1283
FCF/OCF
1.9926
CF Coverage
-0.3840
ST Coverage
-7.2160
CapEx Coverage
-1.0075
Div&CapEx Cov
-1.0075
P/BV
-2.5518
P/B
-2.5518
P/S
2.7850
P/E
-5.2162
P/FCF
-10.8964
P/OCF
-21.6559
P/CF
-21.6559
PEG
-0.1612
P/S
2.7850
EV Multiple
-44.2296
P/FV
-2.5518
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
20.00K Shares Bought (29.50 %)
47.81K Shares Sold (70.50%)
3 - 6 Months
896.97K Shares Bought (94.10 %)
56.19K Shares Sold (5.90%)
6 - 9 Months
7.70K Shares Bought (99.99 %)
0.00 Shares Sold (0.01%)
9 - 12 Months
102.67K Shares Bought (81.48 %)
23.33K Shares Sold (18.52 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 86.34M | ▲ 96.46M | ▲ 118.86M | ▲ 165.23M | ▲ 167.41M | ▲ 307.06M | ▼ 210.12M |
Cost Of Revenue | 3.76M | ▼ 3.54M | ▲ 4.89M | ▲ 9.33M | ▲ 10.89M | ▲ 106.29M | ▼ 66.27M |
Gross Profit | 82.58M | ▲ 92.92M | ▲ 113.98M | ▲ 155.90M | ▲ 156.52M | ▲ 200.76M | ▼ 143.85M |
Gross Profit Ratio | 0.96 | ▲ 0.96 | ▼ 0.96 | ▼ 0.94 | ▼ 0.93 | ▼ 0.65 | ▲ 0.68 |
Research And Development Expenses | 53.65M | ▲ 81.83M | ▲ 118.01M | ▲ 149.84M | ▲ 188.69M | ▼ 121.35M | ▼ 116.13M |
General And Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 80.89M | ▼ 0.00 |
Selling And Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -4.60M | ▲ 0.00 |
Selling General And Administrative Expenses | 48.67M | ▲ 63.50M | ▲ 75.46M | ▲ 86.55M | ▲ 92.72M | ▼ 76.29M | ▼ 73.27M |
Other Expenses | -937.00K | ▲ 11.21M | ▲ 58.95M | ▼ -31.38M | ▲ 35.76M | ▼ 18.96M | ▼ 1.59M |
Operating Expenses | 108.38M | ▲ 153.30M | ▲ 204.05M | ▲ 252.73M | ▲ 317.18M | ▼ 197.64M | ▼ 189.40M |
Cost And Expenses | 112.14M | ▲ 156.84M | ▲ 208.94M | ▲ 262.06M | ▲ 328.07M | ▼ 303.94M | ▼ 255.67M |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 26.10M | ▼ -84.91M | ▲ 0.00 |
Interest Expense | 0.00 | 0.00 | ▲ 24.29M | ▼ 22.50M | ▲ 24.50M | ▲ 44.28M | ▼ 40.83M |
Depreciation And Amortization | 6.06M | ▲ 7.97M | ▲ 12.40M | ▲ 16.34M | ▲ 70.91M | ▲ 80.71M | ▼ 55.40M |
Ebitda | -396.00K | ▼ -40.01M | ▲ -18.73M | ▼ -111.87M | ▲ -89.75M | ▲ 83.83M | ▼ 9.84M |
Ebitda Ratio | -0.00 | ▼ -0.41 | ▲ -0.16 | ▼ -0.68 | ▲ -0.54 | ▲ 0.27 | ▼ 0.05 |
Operating Income | -45.14M | ▼ -72.78M | ▼ -96.37M | ▲ -84.73M | ▼ -160.66M | ▲ 3.12M | ▼ -45.55M |
Operating Income Ratio | -0.52 | ▼ -0.75 | ▼ -0.81 | ▲ -0.51 | ▼ -0.96 | ▲ 0.01 | ▼ -0.22 |
Total Other Income Expenses Net | -20.28M | ▲ -1.19M | ▲ 52.65M | ▼ -19.28M | ▼ -29.04M | ▼ -160.17M | ▲ -39.14M |
Income Before Tax | -49.32M | ▼ -67.03M | ▲ -61.72M | ▼ -138.61M | ▼ -189.69M | ▲ -157.05M | ▲ -84.70M |
Income Before Tax Ratio | -0.57 | ▼ -0.69 | ▲ -0.52 | ▼ -0.84 | ▼ -1.13 | ▲ -0.51 | ▲ -0.40 |
Income Tax Expense | -993.00K | ▲ 10.64M | ▲ 12.63M | ▼ 4.66M | ▼ -18.81M | ▲ -1.26M | ▲ 6.88M |
Net Income | -48.33M | ▼ -77.68M | ▲ -74.35M | ▼ -143.27M | ▼ -170.89M | ▲ -155.79M | ▲ -91.58M |
Net Income Ratio | -0.56 | ▼ -0.81 | ▲ -0.63 | ▼ -0.87 | ▼ -1.02 | ▲ -0.51 | ▲ -0.44 |
Eps | -0.96 | ▼ -1.25 | ▲ -1.08 | ▼ -2.03 | ▼ -2.35 | ▲ -2.06 | ▲ -1.20 |
Eps Diluted | -0.96 | ▼ -1.25 | ▲ -1.08 | ▼ -2.03 | ▼ -2.35 | ▲ -2.06 | ▲ -1.20 |
Weighted Average Shs Out | 50.33M | ▲ 62.06M | ▲ 68.89M | ▲ 70.67M | ▲ 72.66M | ▲ 75.51M | ▲ 76.50M |
Weighted Average Shs Out Dil | 50.37M | ▲ 62.06M | ▲ 68.91M | ▲ 70.67M | ▲ 72.66M | ▲ 75.51M | ▲ 76.50M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 227.59M | ▲ 686.56M | ▼ 208.81M | ▲ 773.38M | ▼ 410.71M | ▲ 594.00M | ▼ 548.36M |
Short Term Investments | 58.09M | ▲ 398.54M | ▲ 894.84M | ▼ 583.66M | ▼ 130.87M | ▲ 282.74M | ▲ 336.46M |
Cash And Short Term Investments | 227.59M | ▲ 686.56M | ▲ 1.10B | ▼ 773.38M | ▼ 410.71M | ▲ 876.74M | ▲ 884.81M |
Net Receivables | 67.91M | ▼ 55.54M | ▲ 69.93M | ▲ 110.46M | ▲ 155.61M | ▲ 161.02M | ▲ 198.46M |
Inventory | 16.12M | ▲ 19.29M | ▼ 18.70M | ▼ 15.86M | ▲ 21.81M | ▲ 30.58M | ▼ 30.06M |
Other Current Assets | 9.25M | ▲ 17.90M | ▲ 39.47M | ▲ 54.68M | ▲ 105.66M | ▲ 150.29M | ▼ 55.41M |
Total Current Assets | 320.86M | ▲ 779.28M | ▲ 1.23B | ▼ 773.38M | ▼ 693.79M | ▲ 1.22B | ▼ 1.17B |
Property Plant Equipment Net | 12.69M | ▲ 21.55M | ▲ 118.24M | ▲ 130.01M | ▲ 175.02M | ▲ 178.99M | ▲ 183.97M |
Goodwill | 82.34M | 82.34M | 82.34M | 82.34M | 82.34M | 82.34M | 82.34M |
Intangible Assets | 701.03M | ▲ 710.50M | ▲ 715.33M | ▲ 724.84M | ▼ 705.89M | ▼ 379.50M | ▼ 330.04M |
Goodwill And Intangible Assets | 783.37M | ▲ 792.84M | ▲ 797.67M | ▲ 807.18M | ▼ 788.23M | ▼ 461.84M | ▼ 412.38M |
Long Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 16.09M | ▲ 16.28M | ▼ 16.27M |
Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -16.09M | ▲ 7.48M | ▼ 0.00 |
Other Non Current Assets | 2.30M | ▲ 30.11M | ▲ 60.62M | ▲ 227.49M | ▼ 48.58M | ▼ 19.96M | ▼ 8.28M |
Total Non Current Assets | 798.37M | ▲ 844.50M | ▲ 976.53M | ▲ 1.16B | ▼ 1.01B | ▼ 684.55M | ▼ 620.89M |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 |
Total Assets | 1.12B | ▲ 1.62B | ▲ 2.21B | ▼ 1.94B | ▼ 1.71B | ▲ 1.90B | ▼ 1.79B |
Account Payables | 6.00M | ▲ 10.32M | ▲ 18.67M | ▲ 23.03M | ▲ 27.27M | ▼ 6.05M | ▲ 27.46M |
Short Term Debt | 11.67M | ▲ 20.00M | ▼ 8.74M | ▲ 159.81M | ▼ 12.37M | ▲ 16.00M | ▲ 16.52M |
Tax Payables | 0.00 | 0.00 | ▲ 4.32M | ▼ 1.29M | ▲ 4.71M | ▼ 0.00 | ▲ 1.83M |
Deferred Revenue | 3.72M | ▲ 8.24M | ▼ 4.15M | ▲ 265.75M | ▼ 1.35M | ▼ 801.00K | ▲ 1.83M |
Other Current Liabilities | 145.41M | ▲ 197.29M | ▲ 245.78M | ▼ 60.75M | ▲ 365.25M | ▲ 580.25M | ▼ 528.73M |
Total Current Liabilities | 166.80M | ▲ 235.86M | ▲ 277.33M | ▲ 509.35M | ▼ 406.24M | ▲ 603.10M | ▼ 574.55M |
Long Term Debt | 141.35M | ▲ 293.86M | ▲ 411.70M | ▲ 431.43M | ▲ 691.26M | ▼ 284.21M | ▲ 284.51M |
Deferred Revenue Non Current | 13.44M | ▼ 11.66M | ▲ 240.40M | ▼ -137.11M | ▲ 1.35M | ▲ 114.81M | ▲ 120.41M |
Deferred Tax Liabilities Non Current | 122.03M | ▲ 130.86M | ▲ 136.74M | ▲ 137.11M | ▼ 102.83M | ▼ 63.39M | ▼ 55.90M |
Other Non Current Liabilities | 324.88M | ▲ 357.22M | ▲ 660.13M | ▲ 733.99M | ▲ 851.03M | ▲ 1.66B | ▼ 1.65B |
Total Non Current Liabilities | 601.70M | ▲ 793.60M | ▲ 1.45B | ▼ 1.17B | ▲ 1.65B | ▲ 2.12B | ▼ 2.11B |
Other Liabilities | 0.00 | 0.00 | 0.00 | ▲ 261.85M | ▼ 0.00 | 0.00 | ▲ 1.00 |
Capital Lease Obligations | 0.00 | 0.00 | ▲ 111.29M | ▼ 103.95M | ▲ 131.91M | ▼ 114.81M | ▲ 120.41M |
Total Liabilities | 768.50M | ▲ 1.03B | ▲ 1.73B | ▲ 1.94B | ▲ 2.05B | ▲ 2.72B | ▼ 2.68B |
Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock | 51.00K | ▲ 62.00K | ▲ 70.00K | ▲ 71.00K | ▲ 72.00K | ▲ 75.00K | ▲ 76.00K |
Retained Earnings | -938.92M | ▼ -1.19B | ▼ -1.63B | ▼ -2.10B | ▼ -2.66B | ▼ -3.28B | ▼ -3.38B |
Accumulated Other Comprehensive Income Loss | 1.46M | ▼ -10.58M | ▼ -60.96M | ▲ -24.28M | ▲ 4.80M | ▼ -1.29M | ▼ -5.56M |
Other Total Stockholders Equity | 1.29B | ▲ 1.80B | ▲ 2.17B | ▼ 2.12B | ▲ 2.31B | ▲ 2.47B | ▲ 2.49B |
Total Stockholders Equity | 350.73M | ▲ 594.33M | ▼ 481.98M | ▼ 1.44M | ▼ -347.09M | ▼ -818.56M | ▼ -893.92M |
Total Equity | 350.73M | ▲ 594.33M | ▼ 481.98M | ▼ 1.44M | ▼ -347.09M | ▼ -818.56M | ▼ -893.92M |
Total Liabilities And Stockholders Equity | 1.12B | ▲ 1.62B | ▲ 2.21B | ▼ 1.94B | ▼ 1.71B | ▲ 1.90B | ▼ 1.79B |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 1.12B | ▲ 1.62B | ▲ 2.21B | ▼ 1.94B | ▼ 1.71B | ▲ 1.90B | ▼ 1.79B |
Total Investments | 58.09M | ▲ 398.54M | ▲ 894.84M | ▼ 583.66M | ▼ 130.87M | ▲ 299.02M | ▲ 352.73M |
Total Debt | 153.01M | ▲ 313.86M | ▲ 420.44M | ▲ 431.43M | ▲ 703.63M | ▼ 415.03M | ▲ 421.44M |
Net Debt | -74.57M | ▼ -372.70M | ▲ 211.63M | ▼ -341.94M | ▲ 292.92M | ▼ -178.98M | ▲ -126.91M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -48.33M | ▼ -77.68M | ▲ -74.35M | ▼ -143.27M | ▼ -170.89M | ▲ -155.79M | ▲ -91.58M |
Depreciation And Amortization | 6.77M | ▲ 9.28M | ▲ 12.40M | ▲ 18.81M | ▲ 38.87M | ▲ 80.71M | ▼ 55.40M |
Deferred Income Tax | 836.00K | ▲ 8.83M | ▼ 5.87M | ▼ 377.00K | ▼ -34.28M | ▲ 3.98M | ▼ -1.00K |
Stock Based Compensation | 8.48M | ▲ 11.47M | ▲ 21.42M | ▲ 26.24M | ▲ 27.34M | ▼ 16.51M | ▲ 18.38M |
Change In Working Capital | -4.33M | ▲ 27.81M | ▼ 1.55M | ▼ -5.85M | ▼ -21.09M | ▼ -82.61M | ▲ 65.51M |
Accounts Receivables | -26.91M | ▲ 5.65M | ▼ -10.60M | ▼ -16.37M | ▼ -23.70M | ▲ 8.35M | ▼ -39.50M |
Inventory | -2.57M | ▲ -1.88M | ▲ 1.45M | ▼ -676.00K | ▼ -5.90M | ▲ 5.94M | ▼ 120.00K |
Accounts Payables | 43.88M | ▼ 26.84M | ▲ 70.80M | ▼ 45.66M | ▼ 36.60M | ▼ -30.00K | ▼ -5.39M |
Other Working Capital | -18.73M | ▲ -2.79M | ▼ -60.09M | ▲ -34.47M | ▲ -28.09M | ▼ -96.87M | ▲ 104.89M |
Other Non Cash Items | 21.43M | ▼ 10.09M | ▼ -31.25M | ▲ 34.85M | ▼ -5.92M | ▲ 36.92M | ▲ 191.60M |
Net Cash Provided By Operating Activities | -15.14M | ▲ -10.21M | ▼ -64.37M | ▼ -68.84M | ▼ -165.96M | ▲ -100.29M | ▲ 70.76M |
Investments In Property Plant And Equipment | -9.14M | ▼ -16.09M | ▼ -18.87M | ▼ -24.04M | ▼ -27.00M | ▼ -28.46M | ▼ -64.35M |
Acquisitions Net | -48.89M | ▲ 11.43M | ▲ 12.52M | ▼ -1.67M | ▲ 128.44M | ▼ -35.89M | ▲ 0.00 |
Purchases Of Investments | -39.96M | ▼ -254.68M | ▼ -432.72M | ▲ -61.41M | ▲ -12.34M | ▼ -186.11M | ▲ -113.44M |
Sales Maturities Of Investments | 24.50M | ▲ 41.77M | ▲ 243.47M | ▼ 153.72M | ▼ 71.77M | ▲ 120.15M | ▼ 62.86M |
Other Investing Activities | 48.89M | ▼ -11.43M | ▼ -12.52M | ▲ 1.67M | ▼ -128.44M | ▲ 35.89M | ▼ -105.34M |
Net Cash Used For Investing Activities | -24.60M | ▼ -229.00M | ▲ -208.12M | ▲ 68.27M | ▼ 32.44M | ▼ -94.42M | ▼ -114.93M |
Debt Repayment | 0.00 | ▼ -5.00M | ▲ 0.00 | 0.00 | ▼ -150.00M | ▼ -381.65M | ▲ -1.49M |
Common Stock Issued | 1.00K | ▼ -506.00K | ▲ 0.00 | 0.00 | ▲ 54.77M | ▼ 2.42M | ▼ 2.03M |
Common Stock Repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 3.73M | ▲ 7.79M | ▲ 40.09M | ▼ 4.35M | ▲ 398.15M | ▲ 999.72M | ▼ 2.03M |
Net Cash Used Provided By Financing Activities | 3.73M | ▼ 2.28M | ▲ 40.09M | ▼ 4.35M | ▲ 302.92M | ▲ 620.49M | ▼ 540.00K |
Effect Of Forex Changes On Cash | -1.40M | ▲ 1.37M | ▲ 7.24M | ▼ -3.89M | ▲ 6.02M | ▼ 3.10M | ▼ -2.03M |
Net Change In Cash | -37.42M | ▼ -235.55M | ▲ -225.16M | ▲ -100.00K | ▲ 175.41M | ▲ 428.84M | ▼ -45.65M |
Cash At End Of Period | 169.50M | ▲ 295.53M | ▼ 216.31M | ▼ 197.22M | ▲ 295.93M | ▲ 594.00M | ▼ 548.36M |
Cash At Beginning Of Period | 206.91M | ▲ 531.08M | ▼ 441.47M | ▼ 197.32M | ▼ 120.51M | ▲ 165.16M | ▲ 594.00M |
Operating Cash Flow | -15.14M | ▲ -10.21M | ▼ -64.37M | ▼ -68.84M | ▼ -165.96M | ▲ -100.29M | ▲ 70.76M |
Capital Expenditure | -9.14M | ▼ -16.09M | ▼ -18.87M | ▼ -24.04M | ▼ -27.00M | ▼ -28.46M | ▼ -64.35M |
Free Cash Flow | -24.28M | ▼ -26.29M | ▼ -83.23M | ▼ -92.88M | ▼ -192.96M | ▲ -128.75M | ▲ 6.41M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)